Brian Powl
Corporate Officer/Principal en KURA ONCOLOGY, INC. .
Fortuna: 444 235 $ al 30/04/2024
Cargos activos de Brian Powl
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KURA ONCOLOGY, INC. | Corporate Officer/Principal | 14/08/2023 | - |
Historial de carrera de Brian Powl
Antiguos cargos conocidos de Brian Powl.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | - | - |
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | 30/06/2022 | - |
| MEI PHARMA, INC. | Ventas & Marketing | 15/09/2020 | - |
Formación de Brian Powl.
| University of California San Diego | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Corporate Officer/Principal | 3 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Brian Powl
- Experiencia